Rheumatoid Arthritis Posts Page 3 on Medivizor
Navigation Menu

Rheumatoid Arthritis Posts on Medivizor

Evaluating predictors for poor methotrexate response in patients with rheumatoid arthritis: can co-treatment with adalimumab improve disease symptoms?

Posted by on Aug 28, 2018 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated if there are disease features that can predict if a patient with rheumatoid arthritis will respond well to methotrexate treatment. They found that higher disease activity at early stages of treatment predicted a poor treatment response in these patients. Some background Treatment of rheumatoid arthritis (RA)...

Read More

Clinical Trials Today

Clinical Trials Today

Posted by on Aug 26, 2018 in Benign prostatic hyperplasia, Blog, Breast cancer, Colorectal cancer, Coronary artery disease, Diabetes mellitus, Erectile dysfunction, Hodgkin's lymphoma, Hypertension, Infertility, Kidney stones, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Nocturia, Non-Hodgkin lymphoma, Overactive bladder, Parkinson's Disease, Prostate cancer, Rheumatoid Arthritis, Stroke, Urinary incontinence, Urinary tract infection | 8 comments

Prior to the 20th century, most people lived about 47 years in the developed world because of infectious diseases. In 1940, the first use of penicillin to treat infectious diseases occurred and penicillin became available in 1945 to the general public. Science and research conducted throughout the 1950s, 60s, and 70s, created more antibiotics so that life...

Read More

Does tocilizumab treatment result in improved work productivity in patients with rheumatoid arthritis?

Posted by on Aug 13, 2018 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated whether tocilizumab (Actemra) treatment improves work productivity in patients with rheumatoid arthritis. They found that house workers treated with tocilizumab were more productive and better quality of life compared to patients taking synthetic disease-modifying drugs. Some background One of the...

Read More

Is an infliximab biosimilar safe and effective for methotrexate-resistant rheumatoid arthritis?

Posted by on Aug 13, 2018 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated if an infliximab (Remicade) biosimilar is safe and effective to treat rheumatoid arthritis. They found that the infliximab biosimilar PF-06438179/GP1111 was similarly effective as standard infliximab and well tolerated. Some background Biosimilars are medicines that act in the same way as the original...

Read More

Assessing the potential of certolizumab pegol treatment for moderate/severe rheumatoid arthritis: is it a matter of time?

Posted by on Aug 13, 2018 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated the timepoint at which certolizumab pegol treatment is effective in treating rheumatoid arthritis. They found that the effectiveness of certolizumab pegol treatment at 12 weeks predicts future treatment success at 52 weeks. Some background Certolizumab pegol (CZP) is a new biologic drug that blocks activity of...

Read More

Upadacitinib: a safe and effective rheumatoid arthritis treatment for patients resistant to csDMARDs

Posted by on Aug 9, 2018 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated whether upadacitinib is a safe and effective treatment for unresponsive patients with rheumatoid arthritis (RA). They concluded that upadacitinib improved RA symptoms in combination with csDMARDs and was well tolerated.  Some background ne type of medication used to treat rheumatoid arthritis...

Read More

Upadacitinib: a safe and effective medication to treat rheumatoid arthritis?

Posted by on Aug 9, 2018 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated the safety and effectiveness of upadacitinib for the treatment of rheumatoid arthritis. They found that upadacitinib is a safe and effective treatment for RA. Some background Disease-modifying anti-rheumatic drugs (DMARDs) are one of the standard medications to treat rheumatoid arthritis (RA). Biological...

Read More

Do glucocorticoid drugs affect bone density in patients with rheumatoid arthritis?

Posted by on Aug 9, 2018 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated if glucocorticoid drugs affect bone mineral density in patients with rheumatoid arthritis. They found that the use of glucocorticoid drugs was not associated with changes in bone mineral density. Some background To treat rheumatoid arthritis (RA), patients are prescribed medication to reduce inflammation. One...

Read More

Sustaining remission in rheumatoid arthritis and identifying suitable patients for tapered treatment

Posted by on Jul 14, 2018 in Rheumatoid Arthritis | 0 comments

In a nutshell This study examined the features of long-term disease remission in patients with rheumatoid arthritis (RA) on reduced treatment. The study concluded that disease activity, synovitis, rheumatoid factor and a history of smoking are associated with treatment failure. Some background Biological (b)DMARDs (disease-modifying...

Read More